Zobrazeno 1 - 10
of 815
pro vyhledávání: '"Adverse cutaneous drug reaction"'
Publikováno v:
Indian Dermatology Online Journal, Vol 15, Iss 4, Pp 678-680 (2024)
Externí odkaz:
https://doaj.org/article/17323f6e0c5342a7b3b0ef9e302cae4b
Autor:
Tyagi, Mehul1, Ahuja, Rhea1, Patel, Varniraj1, Sahni, Kanika1, Taneja, Neha1, Gupta, Somesh1 someshgupta@aiims.edu
Publikováno v:
Indian Dermatology Online Journal. Jul/Aug2024, Vol. 15 Issue 4, p678-680. 3p.
Publikováno v:
Saintika Medika, Vol 16, Iss 2, Pp 149-158 (2020)
Adverse cutaneous drug reaction (ACDR) is a challenging condition for clinician, especially in determining the etiologic drug. Identification of etiologic drug become more difficult when the patient consume multiple drugs at once. As cellular immunit
Externí odkaz:
https://doaj.org/article/b632e4f94e334b20b471d2bcdb659813
Autor:
Dyah Ayu Mira Oktarina, Maria Sophiati, Erinda Maharani Rambu Moha, Fajar Waskito, Hardyanto Soebono
Publikováno v:
Berkala Ilmu Kesehatan Kulit dan Kelamin (Periodical of Dermatology and Venerology), Vol 33, Iss 3, Pp 150-155 (2021)
Background: The prevalence of adverse drug reactions is likely to increase, and it is associated with increased usage of various drugs. Adverse Cutaneous Drug Reaction (ACDR) is the most frequent adverse drug reaction (30–45%). In Indonesia, the st
Externí odkaz:
https://doaj.org/article/fc3aded765f349f8aefb461b45359125
Publikováno v:
European Medical Journal Dermatology (2022)
This paper describes an unreported case of a rifaximin-induced phototoxic reaction in an otherwise healthy 24-year-old female (skin type: V). The patient developed malaise, chills, and facial swelling with accompanying redness and itching that began
Externí odkaz:
https://doaj.org/article/ebdb19b019f04198829b66fd5b7a5353
Publikováno v:
Indian Journal of Pharmacology. Sep/Oct2020, Vol. 52 Issue 5, p430-434. 5p.
Publikováno v:
South African Family Practice. 2015, Vol. 57 Issue 4, p226-230. 5p.
Publikováno v:
Indian Journal of Pharmacology
Paclitaxel-induced photodermatitis is extremely rare despite the frequent use of paclitaxel-trastuzumab combination chemotherapy. A 70-year-old woman with infiltrating intraductal breast cancer developed photodermatitis after ten treatment courses of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76749c711b267ae87c34f55a68d332e0
http://europepmc.org/articles/PMC8025759
http://europepmc.org/articles/PMC8025759
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 7, Iss 12, Pp 2765-2767 (2013)
Introduction: The number of subjects involved in a clinical trial are limited, whose findings cannot be extrapolated to the entire population.Due to the emergence of newer molecules the pattern of Adverse Cutaneous Drug Reaction(ACDR) also change
Externí odkaz:
https://doaj.org/article/65f93e16c92d487198ae615ba83c0c67